Zacks: Brokerages predicts National Health Investors, Inc. (NYSE: NHI) to post quarterly sales of $ 68.45 million


Equity research analysts expect National Health Investors, Inc. (NYSE: NHI) to post sales of $ 68.45 million for the current fiscal quarter, Zacks reports. Two analysts have provided earnings estimates for National Health Investors. The lowest sales estimate is $ 66.40 million and the highest is $ 70.49 million. National Health Investors reported sales of $ 81.24 million in the same quarter last year, indicating a negative year-over-year growth rate of 15.7%. The company is expected to release its next earnings report on Monday, February 28.

On average, analysts expect National Health Investors to report annual revenue of $ 297.52 million for the current year, with estimates ranging from $ 295.50 million to $ 299.54. millions of dollars. For the next fiscal year, analysts predict the company will post revenue of $ 307.92 million, with estimates ranging from $ 276.20 million to $ 339.65 million. Zacks sales averages are an average based on a survey of sales analysts who cover National Health Investors.

National Health Investors (NYSE: NHI) last released its quarterly results on Monday, November 8. The REIT reported earnings of $ 0.67 per share for the quarter, missing the Zacks’ consensus estimate of $ 1.18 of ($ 0.51). National Health Investors reported a return on equity of 9.20% and a net margin of 45.92%. The company posted revenue of $ 73.83 million for the quarter, compared to analysts’ estimates of $ 74.21 million. In the same quarter of the previous year, the company posted earnings per share of $ 1.42. The company’s revenue was down 12.4% year-on-year.

INSA has been the subject of a number of recent analyst reports. Truist lowered its price target on National Health Investors from $ 71.00 to $ 64.00 and set a “conservation” rating for the company in a report released Thursday, September 23. Zacks Investment Research downgraded National Health Investors from a “hold” rating to a “sell” rating in a report released on Tuesday, November 2. Truist Securities lowered its price target for the National Health Investors stock from $ 71.00 to $ 64.00 and set a “hold” rating on the stock in a research report released Thursday, September 23. TheStreet reduced shares of National Health Investors from a “b-” rating to a “c +” rating in a research report released on Friday, October 8. Finally, Capital One Financial downgraded National Health Investors shares from a “peer-to-peer” rating to an “overweight” rating in a research report released on Tuesday, November 9. Two analysts gave the stock a sell rating, four assigned a conservation rating and one assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $ 68.29.

(A d)

It’s scientific breakthroughs like this that give investors like you the chance to quickly jump into companies that will revolutionize the world …

And you might only have one opportunity in your life to invest in something this big …

In addition, director Robert T. Webb bought 2,000 shares of the company in a transaction on Wednesday, December 1. The shares were purchased at an average price of $ 51.60 per share, for a total value of $ 103,200.00. The purchase was disclosed in a document filed with the SEC, accessible through this link. In addition, director Robert T. Webb bought 1,000 shares of the company in a trade on Monday, November 29. The shares were purchased at an average cost of $ 52.86 per share, for a total transaction of $ 52,860.00. Disclosure of this purchase can be found here. 6.55% of the shares are currently held by insiders of the company.

Several institutional investors have recently bought and sold shares of NHI. MV Capital Management Inc. purchased a new equity stake in National Health Investors during the third quarter valued at approximately $ 27,000. Marshall Wace North America LP purchased a new equity stake in National Health Investors during the first quarter valued at approximately $ 31,000. Samalin Investment Counsel LLC acquired a new position in National Health Investors in the 2nd quarter for a value of approximately $ 36,000. Allworth Financial LP increased its stake in National Health Investors by 143.3% in the 3rd quarter. Allworth Financial LP now owns 730 real estate investment trust shares valued at $ 39,000 after purchasing 430 additional shares in the last quarter. Finally, Rockefeller Capital Management LP increased its stake in National Health Investors by 262.1% in the 2nd quarter. Rockefeller Capital Management LP now owns 659 shares of the REIT valued at $ 44,000 after purchasing an additional 477 shares in the last quarter. 63.79% of the shares are currently held by hedge funds and other institutional investors.

National Health Investors shares opened at $ 59.16 on Thursday. The company has a debt ratio of 0.83, a rapid ratio of 20.73 and a current ratio of 20.73. The stock’s 50-day simple moving average is $ 55.67. National Health Investors has a one-year low of $ 50.88 and a one-year high of $ 78.56. The company has a market cap of $ 2.71 billion, a P / E ratio of 18.90 and a beta of 0.95.

The company also recently declared a quarterly dividend, which will be paid on Monday, January 31. Investors of record on Friday, December 31 will receive a dividend of $ 0.90. The ex-dividend date for this dividend is Thursday, December 30. This represents an annualized dividend of $ 3.60 and a return of 6.09%. National Health Investors’ payout ratio is 115.02%.

About National Health Investors

National Health Investors, Inc. is a real estate investment trust, engaged in sale and leaseback, joint venture, mortgage and mezzanine financing of senior housing and medical investments. Its portfolio includes leases, mortgages and other investments in independent residences, assisted living facilities, paying communities, senior campuses, skilled nursing facilities, specialty hospitals and medical office buildings.

Recommended Story: Pros / Cons Explained

Get a Free Copy of Zacks’ National Health Investor (NHI) Research Report

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

History and Estimates of Profits for National Health Investors (NYSE: NHI)

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]

Should You Invest $ 1,000 In National Health Investors Now?

Before you consider National Health Investors, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold of… and National Health Investors was not on the list.

While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here


Comments are closed.